← Entities Public Body

Unidade Local de Saúde Santa Maria, E.P.E.

NIF TED-d31c3d70ef42 · PT

Risk Flags

A5 · Threshold Splitting €0 36 contracts

Contract value falls within 5% below a procedural threshold (€5K / €20K / €75K / €150K / €5.35M). Score: 35 · Severity: Medium.

HIGH €0 36 contracts

B5 · Benford's Law Deviation €0 1,877 contracts

Entity's contract values deviate from the Benford leading-digit distribution (chi-square goodness-of-fit, min 20 contracts). Score: 35 (p<0.05) or 55 (p<0.01).

MEDIUM €0 1,877 contracts

C3 · Missing Mandatory Fields €0 7 contracts

CPV code, procedure type, or base price absent for the procedure type, or base price exceeds ±€1 trillion (implausible data entry). Score: 20 · Severity: Low.

LOW €0 7 contracts

Procurement Network

Aggregated links between this entity and connected counterparties

Public view excludes person-level links and tax identifiers.

Loading network…

Summary

Nodes 0

Edges 0

Truncated -

Selected Node

Type -

Contracts -

Total Value -

Relation -

Outgoing -

Incoming -

Connected Entities -

Flagged Contracts -

Risk Score -

Legend Focus entity Public body Company Anonymized individual

Signal: All A5 · Threshold Splitting B5 · Benford's Law Deviation C3 · Missing Mandatory Fields

Page 2 of 38 · 1,884 results

Contract Winner Procedure Base Price Date ↓

Portugal – Blood products – 261G000180-C.Central Medicamentos - 2026/0126 - BEDAQUILINA

PT · 65971-2026

A5 · Threshold Splitting

Portugal – Blood products – 261G000161- EFMOROCTOCOG ALFA (ELOCTA)

Portugal – Cleaning and sanitation services – 269G000038 - Prestação de Prestação de serviços de Higiene e Limpeza das Instalações do Centro Hospitalar Universitário de Lisboa Norte, E.P.E., em janeiro de 2026

Portugal – Residential health facilities services – 269G000042

Portugal – Residential health facilities services – 269G000041

Portugal – Residential health facilities services – 269G000040

Portugal – Rehabilitation services – 269G000039 - “Prestação de serviços de internamento e de cuidados de saúde a utentes da Unidade Local de Saúde de Santa Maria, E.P.E. – 10 camas de retaguarda de tipologia de unidade longa duração e manutenção, para os meses de janeiro e fevereiro de 2026

Portugal – Residential health facilities services – 269G000044

Portugal – Storage services – 259C000152 – “Prestação de Serviços de Armazenamento e Transporte de Produtos Farmacêuticos em regime de Outsourcing à Unidade Local de Saúde de Santa Maria, E.P.E., de dezembro de 2025 a dezembro de 2026”.

PT · 45073-2026

—

oth-single €74,999,000

€74,999,000

—

Portugal – Collection, transport and disposal of hospital waste – 269G000058 - “Prestação de serviços de recolha e tratamento de Resíduos produzidos nas Instalações da Unidade Local de Saúde de Santa Maria - Unidades hospitalares da ULSSM (Hospital de Santa Maria e Parque Saúde Pulido Valente) no mês de janeiro de 2026”

PT · 41448-2026

—

oth-single €172,161,980

€172,161,980

—

Portugal – Collection, transport and disposal of hospital waste – 269A000004 - Prestação de serviços de recolha e tratamento de Resíduos produzidos nas Instalações da Unidade Local de Saúde de Santa Maria - Unidades hospitalares da ULSSM (Hospital de Santa Maria e Parque Saúde Pulido Valente) e Unidades de Cuidados de Saúde Primários (Lisboa Norte e Mafra) - nos meses de janeiro a março de 2026

Portugal – Meal-cooking services – 269G000063 - Prestação de serviços de fornecimento de alimentação a doentes e colaboradores da Unidade Local de Saúde de Santa Maria, E.P.E., em janeiro de 2026

Portugal – Social work services with accommodation – 269X000004

Portugal – Collection, transport and disposal of hospital waste – 269X000008 - Prestação de serviços de recolha e tratamento de resíduos das Unidades de Cuidados de Saúde Primários da Unidade Local de Saúde de Santa Maria, E.P.E., janeiro de 2026

PT · 17313-2026

—

oth-single €4,972,500

€4,972,500

—

Portugal – Cleaning and sanitation services – 259G002483 - “Prestação de serviços de higiene e limpeza das instalações das Unidades Hospitalares da Unidade Local de Saúde de Santa Maria, E.P.E., de 01/12/2025 a 31/12/2025”

Portugal – Electricity distribution – 259A000023

Portugal – Rehabilitation services – 269X000002

Portugal – Rehabilitation services – 269X000003

Portugal – Medicinal products for the nervous system – 2025/1303 - VUTRISIRAN [50 MG/ML 0,5 ML SERINGA]

PT · 867229-2025

—

restricted €7,160,597

€7,160,597

—

Portugal – Parenteral nutrition products – 2025/1441 - MIGALASTATE

Portugal – Parenteral nutrition products – 2025/1441 - ELOSULFASE

Portugal – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – 2023/0671 - LETERMOVIR [240 MG CÁP/COMP]

Portugal – Antineoplastic and immunomodulating agents – 2023/0491- GILTERITINIB [40 MG CÁP/ COMP]

Portugal – Parenteral nutrition products – 2022/0058 - MIGALASTATE [123 MG CÁP/ COMP]

Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - DURVALUMAB [50 MG/ ML 10 ML FRS]

Portugal – Antineoplastic and immunomodulating agents – 2025/1303 - ACALABRUTINIB [100 MG CÁP/COMP]

Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - DURVALUMAB [50 MG/ ML 10 ML FRS]

Portugal – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – 2023/0671 - LETERMOVIR [240 MG CÁP/COMP]

Portugal – Medicinal products for the blood, blood-forming organs and the cardiovascular system – 2023/0304- LUSPATERCEPT [75 MG PÓ SOL INJ FRS]

Portugal – Antineoplastic and immunomodulating agents – 2025/1303 - TRASTUZUMAB DERUXTECANO [100 MG PÓ CONC SOL INJ FRS]

Portugal – Medicinal products for the blood, blood-forming organs and the cardiovascular system – 2023/0304- LUSPATERCEPT [75 MG PÓ SOL INJ FRS]

Portugal – Antineoplastic and immunomodulating agents – 2023/0491- GILTERITINIB [40 MG CÁP/ COMP]

Portugal – Blood products – 251G001684- DAMOCTOCOG ALFA PEGOL 2000 UI / 2,5 ML INJ ( JIVI )

Portugal – Medicinal products for the respiratory system – 2024/0899 - MEPOLIZUMAB [100 MG/1 ML SOL INJ CANETA]

Portugal – Antineoplastic and immunomodulating agents – 2023/0491- GILTERITINIB [40 MG CÁP/ COMP]

Portugal – Antineoplastic and immunomodulating agents – 2025/1303 - ACALABRUTINIB [100 MG CÁP/COMP]

Portugal – Parenteral nutrition products – 2022/0058 - MIGALASTATE [123 MG CÁP/ COMP]

Portugal – Antineoplastic and immunomodulating agents – 2025/1303 - DUPILUMAB [300 MG/ 2 ML SOL INJ CANETA]

Portugal – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – 2024/0900 - LAMIVUDINA + DOLUTEGRAVIR [300 MG + 50 MG COMP]

PT · 836480-2025

—

restricted €3,688,632

€3,688,632

—

Portugal – Medicinal products for the respiratory system – 2024/0899-BENRALIZUMAB [30 MG/1 ML SOL INJ CANETA/ SERINGA]

Portugal – Medicinal products for the respiratory system – 2024/0899-BENRALIZUMAB [30 MG/1 ML SOL INJ CANETA/ SERINGA]

Portugal – Medicinal products for the respiratory system – 2024/0899-BENRALIZUMAB [30 MG/1 ML SOL INJ CANETA/ SERINGA]

Portugal – Parenteral nutrition products – 2022/0058 - ELOSULFASE ALFA [1 MG/ML 5 ML SOL INJ F/AMP]

Portugal – Antineoplastic and immunomodulating agents – 2025/1303 - DUPILUMAB [300 MG/ 2 ML SOL INJ CANETA]

Portugal – Antineoplastic and immunomodulating agents – 2023/0491- RUXOLITINIB [20 MG CÁP/COMP]

PT · 834437-2025

A5 · Threshold Splitting

Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - OFATUMUMAB [20 MG/0.4 ML SOL INJ CANETA]

Portugal – Refuse disposal and treatment – 259X000536 - Prestação de Gestão de Serviços de Transportes e Distribuição de Medicamentos aos Utentes da Unidade Local de Saúde de Santa Maria, E.P.E.

Portugal – Antineoplastic and immunomodulating agents – 2023/0491- RUXOLITINIB [20 MG CÁP/COMP]

Portugal – Medicinal products for the nervous system – 2023/0436 - TAFAMIDIS [61 MG CÁP/COMP]

Portugal – Medicinal products for the nervous system – 2023/0671- ONASEMNOGENE ABEPARVOVEC [2 X10E13 VG/ML 22,1 ML SOL INJ FRS]

PT · 833497-2025

—

restricted €1,855,141

€1,855,141

—

← Prev Next →

Overview

Total Contracts

1,884

Score 1455 · CRITICAL RISK

Digit Distribution

n = 1,877 contracts · χ² = 59.8021

22.8%

20.1%

14.4%

9.9%

9.7%

7.7%

6.6%

4.7%

4.1%

Observed Expected (Benford)